The France In Vitro Fertilization Market was valued at $31.38 Million in 2024 and projected to reach to $49.46 Million by 2029, representing a compound annual growth rate of 9.5%. France's IVF market is poised for sustained growth through 2029, driven by increasing awareness of fertility treatments, technological advancements in reproductive medicine, and evolving social attitudes toward assisted conception.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
France's IVF market reached USD 31.38 million in 2024 and is expected to grow to USD 49.46 million by 2029, demonstrating robust expansion at a 9.5% CAGR, outpacing many European counterparts.
Increasing infertility rates across France, driven by delayed childbearing, lifestyle factors, and environmental influences, are propelling demand for assisted reproductive technologies and IVF treatments.
France boasts state-of-the-art fertility clinics and research institutions equipped with cutting-edge reproductive technologies, positioning the country as a leader in European IVF innovation and treatment outcomes.
France's progressive healthcare policies, including partial reimbursement of IVF treatments through the French healthcare system, create favorable conditions for market expansion and patient accessibility.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | FROZEN NON-DONORS (Type) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 11.7% from 2024 to 2029 |
| Largest Segment | EQUIPMENT (Product) |
| Market Size Base Year (Billions) | ~USD 0.95 (2024) |
| Revenue Forecast (Billions) | ~USD 1.65 (2029) |
| Segments Covered | Product, Type, Type Of Cycle, Procedure, End User |
5 segment dimensions are covered across the global market.
The In Vitro Fertilization market in France was valued at USD 31.38 million in 2024 and is expected to grow to USD 49.46 million by 2029.
France's IVF market is projected to grow at a compound annual growth rate (CAGR) of 9.5% from 2024 to 2029.
Key growth drivers in France include rising infertility rates, advancing reproductive technologies, supportive reimbursement policies, and increasing awareness of fertility treatment options among aging populations.
France's robust healthcare infrastructure and reimbursement policies make IVF procedures more accessible and affordable for patients, contributing to market expansion and higher treatment adoption rates.
France's IVF market is forecasted to reach USD 49.46 million by 2029, representing a 57.6% increase from the 2024 baseline of USD 31.38 million.
In this research, the utilization of both primary and secondary sources was done to a great extent. This included studying the factors affecting the industry to find out the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and strategies by key players.
The secondary research process involves methods using directories, databases such as D&B Hoovers, Bloomberg Businessweek, Factiva, white papers, annual reports, company filings, investor presentations, and SEC filings, and collation of the database of industry leaders. This would help in fleshing out basic information on key players and market segmentation based upon the trends of the industry at various levels, major developments in the market, and technological perspectives pertaining to the in vitro fertilization market.
Primary research for this report featured interviews with a cross-section of sources from both the supply and demand sides to generate qualitative and quantitative data. On the supply side, there were primary sources from industries represented by CEOs, vice presidents, marketing and sales directors, regional sales managers, technology and innovation directors, and other key executives from leading companies and organizations in product therapy markets. Primary sources on the demand side included but were not limited to: embryologists, clinicians, procurement managers, purchase managers, department heads, and professionals from hospitals, fertility clinics, in vitro fertilization centers, and reference labs, among others. This primary research was hoped to validate market segmentation, identify key market players, and get an overview of the key trends and dynamics of the industry.

To know about the assumptions considered for the study, download the pdf brochure
*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1 billion, Tier 2 = <USD 500 million, and Tier 3 = <USD 100 million.
This report also presents the key players' revenue share analysis for the size of the in vitro fertilization market. The identification of key market participants and insights about their revenues in the in vitro fertilization sector are gathered through phases of primary and secondary research. The secondary research process relied heavily on top players' annual and financial reports, while primary research involved highly exhaustive interviews with key opinion leaders, viz., CEOs, directors, and senior marketing executives.
The methodology adopted to calculate the global market value was on a segment basis. These segmental revenues were then sourced through the revenue data of major solution and service providers. The steps involved in the process are

To know about the assumptions considered for the study, Request for Free Sample Report


The in vitro fertilization market was segmented under various categories and subcategories using the above-mentioned methodology. Thereafter, proper data triangulation and the market segmentation process are carried out to further increase the accuracy of the data for each segment. Factors and trends from both the demand and supply sides were studied. Rigorous employment of both top-down and bottom-up approaches provided the result of the analysis of the in vitro fertilization market.
The in vitro fertilization market refers to the global landscape of Assisted Reproductive Technologies services and products that help a person or a couple conceive. It is a market that represents fertility clinics, hospitals, and even research institutions that provide in vitro fertilization treatments and related services, including medical devices, laboratory equipment, drugs, and consumables used for in vitro fertilization procedures. It also includes the diagnostic tests carried out prior to and in the course of in vitro fertilization, genetic screening technologies, and cryopreservation services. In vitro fertilization market has been used as a generic term describing the portfolio of diverse technologies, services, and products relating to the alleviation of infertility and the promotion of reproductive health.
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global In vitro fertilization market
Full forecast, segment splits, and company analysis for all In Vitro Fertilization Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report